Items where authors include "Walton, Matthew"

Article

Walton, Matthew orcid.org/0000-0003-1932-3689, Bojke, Laura orcid.org/0000-0001-7921-9109, Simmonds, Mark orcid.org/0000-0002-1999-8515 et al. (10 more authors) (2024) Anti–Vascular Endothelial Growth Factor Drugs Compared With Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy:A Cost-Effectiveness Analysis. Value in Health. pp. 907-917. ISSN 1524-4733

Walton, Matthew orcid.org/0000-0003-1932-3689, Hodgson, Robert orcid.org/0000-0001-6962-2893, Eastwood, Alison orcid.org/0000-0003-1079-7781 et al. (7 more authors) (2022) Management of sudden onset severe headache patients presenting to the emergency Department:systematic review of diagnostic accuracy studies. Emergency Medicine Journal. pp. 818-825. ISSN 1472-0205

Beresford, Lucy, Murphy, Peter, Dias, Sofia orcid.org/0000-0002-2172-0221 et al. (7 more authors) (2022) Appraising the Costs of Genomic Testing for Histology-Independent Technologies:An Illustrative Example for NTRK Fusions. Value in Health. pp. 1133-1140. ISSN 1524-4733

Walton, Matthew orcid.org/0000-0003-1932-3689, Sharif, Sahar, Simmonds, Mark orcid.org/0000-0002-1999-8515 et al. (2 more authors) (2019) Tisagenlecleucel for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukaemia in People Aged up to 25 Years:An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. pp. 1209-1217. ISSN 1179-2027

Peron, Mathilde, Llewellyn, Alexis orcid.org/0000-0003-4569-5136, Moe-Byrne, Thirimon orcid.org/0000-0002-2827-9715 et al. (5 more authors) (2018) Adjunctive colposcopy technologies for assessing suspected cervical abnormalities:systematic reviews and economic evaluation. Health technology assessment. pp. 1-260. ISSN 2046-4924

Hodgson, Robert orcid.org/0000-0001-6962-2893, Walton, Matthew orcid.org/0000-0003-1932-3689, Biswas, Mousumi orcid.org/0000-0001-6781-7400 et al. (2 more authors) (2017) Ustekinumab for Treating Moderately to Severely Active Crohn's Disease after Prior Therapy:An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. pp. 1-12. ISSN 1179-2027

Corbett, Mark orcid.org/0000-0002-5937-1493, Chehadah, Fadi, Biswas, Mousumi orcid.org/0000-0001-6781-7400 et al. (8 more authors) (2017) Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs:a systematic review and economic evaluation. Health technology assessment. pp. 1-326. ISSN 2046-4924